Clinical Research Services Market Research Report, Share, and Forecast to 2025

Posted by rekha on October 10th, 2019

The global clinical research services market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Some of the key factors favoring the market growth are rising number of clinical trials performed during the drug development phase, growing R&D activities by pharmaceutical and biotech companies and various pharmaceutical industries depending on clinical research services to develop new drugs and growing instances of chronic ailments. However, strict regulatory approvals for these services and lack of highly skilled professionals are hampering the growth of the market.

Global clinical research services market segmented on the basis of type of service, disease area,end user and region.

For request sample: https://www.precisionbusinessinsights.com/request-sample?product_id=15666

Clinical Trials Dominate the Global Clinical Research Services Market

 Based on type of service, global clinical research services market segmented into clinical trials, diagnostic research, epidemiological studies, genetic studies, prevention research, quality of liferesearch, screening research, treatment research and others. Clinical trials segment held considerable market growth during estimated period. Clinical trials are experiments or observations done in clinical research. Clinical trials are research studies that involve patients or healthy people and are designed to test new treatments. Clinical trials cover a broad range of different types of research. It is the primary way that researchers can find out if a new treatment, like a new drug or diet or medical device is safe and effective in people. Clinical trials are the best way to compare different approaches to preventing and treating illness and health problems. Health professionals and patients need the evidence from trials to know which treatments work best thus increasing the demand for this segment in this market.

North America Leads the Global Clinical Research Services market

 PBI’s global clinical research services market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis.North America region has witnessed considerable growth in this market owing to the large presence of patient population suffering with various diseases such as diabetes, cardio vascular disorders etc and favorable government policies supporting this market. This region is one of the key markets for clinical research services. Also, Europe witnessed considerable growth in this market due to rising activities by various pharma and biotechnological companies.

Strategic Acquisition are the Key Strategies Adopted by Market Players

 Global clinical research services market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2019, Navitas Life Sciences, acquired US based niche full service CRO and health research company, KAI Research Inc. This acquisition creates a world class enterprise making meaningful strides to deliver improved trial outcomes to the bio pharma landscape. The addition of KAI’s capabilities translates to global trial capabilities across North America, Europe and APAC markets.

Key player’s profiles in the report are America Holdings (U.S.), Charles River Laboratories International Inc. (U.S.), Covance Inc. (LabCorp), ICON Plc (Ireland), IQVIA (U.S.), PAREXEL International Corporation (U.S.), Pharmaceutical Product Development, LLC (U.S.), PRA Health Sciences, Inc. (U.S.)

Syneos Health and Wuxi AppTec (Cayman) Inc. (China).

Precision Business Insights (PBI) in its report titled “Global Clinical Research Services Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market.

Detailed Segmentation

 

By Type of Service

o     Clinical Trials

o     Diagnostic Research

o     Epidemiological studies

o     Genetic studies

o     Prevention Research

o     Quality of LifeResearch

o     Screening Research

o     Treatment Research

o     Others

By Disease Area

o     Oncology

o     Infectious Diseases

o     Diabetes

o     Central Nervous System Disorders

o     Cardio Vascular Disorders

o     Others

By End User

o     Research Organizations

o     Pharmaceutical Companies

o     Biotechnological Companies

o     Others

By Geography

o     North America

  • U.S
  • Canada

o     Europe

  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

o     Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

o     Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o     Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

For more information: https://www.precisionbusinessinsights.com/market-reports/global-clinical-research-services-market/

Like it? Share it!


rekha

About the Author

rekha
Joined: July 26th, 2019
Articles Posted: 219

More by this author